Hyperfine, Inc. (NASDAQ:HYPR – Free Report) – Equities research analysts at B. Riley raised their Q3 2025 EPS estimates for shares of Hyperfine in a note issued to investors on Wednesday, May 14th. B. Riley analyst Y. Zhi now forecasts that the company will post earnings of ($0.11) per share for the quarter, up from their previous estimate of ($0.12). B. Riley currently has a “Buy” rating and a $1.00 target price on the stock. The consensus estimate for Hyperfine’s current full-year earnings is ($0.57) per share.
Hyperfine (NASDAQ:HYPR – Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported ($0.12) EPS for the quarter, meeting the consensus estimate of ($0.12). The company had revenue of $2.14 million during the quarter, compared to analysts’ expectations of $2.82 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%.
View Our Latest Research Report on HYPR
Hyperfine Trading Up 0.7%
Shares of NASDAQ:HYPR opened at $0.63 on Monday. The firm has a 50 day moving average of $0.74 and a 200-day moving average of $0.92. The stock has a market capitalization of $48.68 million, a PE ratio of -1.10 and a beta of 1.04. Hyperfine has a 12 month low of $0.57 and a 12 month high of $1.90.
Institutional Investors Weigh In On Hyperfine
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC acquired a new stake in Hyperfine during the 4th quarter worth approximately $25,000. Wealth Enhancement Advisory Services LLC lifted its position in shares of Hyperfine by 64.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock worth $72,000 after purchasing an additional 32,093 shares during the period. EP Wealth Advisors LLC acquired a new position in shares of Hyperfine in the 1st quarter worth approximately $25,000. Renaissance Technologies LLC lifted its position in shares of Hyperfine by 32.9% in the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock worth $187,000 after purchasing an additional 52,500 shares during the period. Finally, AMH Equity Ltd acquired a new position in shares of Hyperfine during the 1st quarter valued at $90,000. 15.03% of the stock is owned by institutional investors.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Featured Stories
- Five stocks we like better than Hyperfine
- 3 REITs to Buy and Hold for the Long Term
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- Most Volatile Stocks, What Investors Need to Know
- What Ray Dalio’s Latest Moves Tell Investors
- What Are Some of the Best Large-Cap Stocks to Buy?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.